XML 39 R28.htm IDEA: XBRL DOCUMENT v3.22.2.2
Organization and Summary of Significant Accounting Policies (Details)
9 Months Ended
Sep. 30, 2022
country
product
segment
Organization And Summary Of Significant Policies [Line Items]  
Number of countries with drug approval, excluding the u.s. | country 62
Number of business segments | segment 1
Resulting from discovery efforts  
Organization And Summary Of Significant Policies [Line Items]  
Number of products that entered in the commercial marketplace 4
Products derived from other compounds  
Organization And Summary Of Significant Policies [Line Items]  
Number of products that entered in the commercial marketplace 2